Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-05-12 @ 7:13 PM
Study NCT ID:
NCT06832267
Status:
RECRUITING
Last Update Posted:
2025-02-18
First Post:
2025-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
Sponsor:
Organization: